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Influenza- and respiratory syncytial virus-associated adult 
mortality in Soweto
A S Karstaedt, M Hopley, M Wong, H H Crewe-Brown, A Tasset-Tisseau
Influenza is a major cause of seasonal excess mortality and 
hospitalisation in adults, particularly the elderly, in temperate 
climates and in subtropical areas.1-9 There is little information 
on the burden of influenza among adults in Africa. An 
outbreak in Madagascar in 2002 had a high attack rate and a 
mortality of 2.5%.10 Regular active surveillance for influenza to 
define seasons and infecting types is conducted in only a few 
African countries, including South Africa.11 Knowledge of the 
local burden of influenza is important to assess the potential 
benefits of a vaccination programme.
Respiratory syncytial virus (RSV) epidemics, which often 
overlap with the influenza season, cause significant morbidity 
and mortality in adults, especially the elderly.3-7,12 Studies of 
both influenza and RSV infections typically employ indirect 
methods because neither infection is routinely confirmed 
virologically.1-7,13
Soweto has a temperate climate with summer rainfall. Viral 
surveillance data from South Africa from 1997 to 1999 revealed 
influenza seasons of varying severity. We aimed to determine 
influenza- and RSV-associated mortality and hospitalisation 
among adults and to stratify these results by ages ≥65 years 
and 18 - 64 years.
Methods
Study design and study population
Ours was a retrospective cohort study of adults admitted to the 
Department of Medicine, Chris Hani Baragwanath Hospital, 
Soweto, from January 1997 to December 1999. To calculate 
mortality and hospitalisation attributable to influenza or RSV, 
we used differences by calendar year between the rates of these 
events when the viruses were circulating, and the rates when 
neither virus was present above baseline levels.
Study site
Chris Hani Baragwanath Hospital is a 2 700-bed public sector 
hospital serving Soweto. The Department of Medicine had 
883 adult medical beds and an average of 27 000 hospitalised 
patients per year. The hospital had paper-based information 
systems with no back-up. There was no classification system 
for discharge diagnoses. The background rate of HIV-infected 
adults in the medical wards was 26% in 1997 and 31% in 1999. 
About 80% of the population of South Africa does not have 
private medical insurance.
Viral surveillance and definitions of study periods
Influenza and RSV seasons were based on weekly isolations of 
the viruses at the National Institute of Virology, Johannesburg, 
which has a sentinel network. Specimens were also supplied 
from a study of children hospitalised at Baragwanath 
Hospital.14,15
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Background. Influenza and respiratory syncytial virus (RSV) 
infections cause seasonal excess mortality and hospitalisation 
in adults (particularly the elderly) in high-income countries. 
Little information exists on the impact of these infections on 
adults in Africa.
Objectives. To estimate influenza- and RSV-related adult 
mortality, stratified by age and hospitalisation in Soweto.
Study design. A retrospective hospital-based study in Soweto 
from 1997 to 1999 to estimate influenza- and RSV-related 
excess all-cause deaths and hospitalisation using a rate-
difference method. The study was based on influenza seasons 
of varying severity, provided by surveillance data.
Results. Influenza seasons were significantly associated with 
excess mortality in adults across all 3 years, except for  
18 - 64-year-olds in 1998. Excess mortality was highest in 
those ≥65 years of age: 82.8/100 000 population in the mild 
1997 season and 220.9/100 000 in the severe 1998 season. 
Influenza significantly increased adult medical hospitalisation 
in the severe 1998 season alone. RSV did not significantly 
affect mortality or hospitalisation.
Conclusion. Influenza-related mortality was substantial and 
disproportionately affected the elderly. Influenza vaccination 
for the elderly warrants consideration. The RSV-related 
burden was not significantly increased but merits observation 
over a longer period.
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Influenza and RSV seasons were defined as the period of at 
least 2 consecutive weeks in which each week accounted for 
≥3% of total annual isolates respectively. The baseline period 
was defined as periods of at least 2 consecutive weeks in which 
both influenza and RSV isolations were <2% of the annual 
total.
Mortality and hospitalisation data
The numbers of adult and paediatric patients who died in 
the hospital were extracted from the mortuary register and 
classified by week. The numbers and ages of adults from 
the medical wards were recorded. All-cause mortality was 
used as there were insufficient data in many patients’ clinical 
records to enable cause of death or predisposing disorder to 
be accurately assigned. The number of all-cause adult medical 
hospitalisations per week was extracted from the admission 
ward register. The data for age and reasons for hospitalisation 
were incomplete.
Excess events
The effects of influenza and RSV were estimated by using a 
rate-difference method.5-7,16 For each calendar year, the average 
number of events (death or hospitalisation) per week was 
calculated for the baseline and the influenza or RSV season. 
The excess events per week were calculated by subtracting 
the baseline rates from the rates during an influenza  or RSV 
season. These results were expressed as a percentage increase. 
The excess rate per week was multiplied by the total number 
of weeks of influenza or RSV predominance to give a total 
number of events in the season. The excess number of events 
was applied to the Soweto population (based on the 1996 
census) to give rates per 100 000 population.
Statistical analysis
Descriptive statistics were calculated using STATISTICA 
(StatSoft, Version 6, Tulsa, USA). The squared coherence, which 
describes the strength of association in time series analysis, is 
reported at a frequency of 52 weeks across all 3 years in the 
dataset. Differences between means, together with the 95% 
confidence interval (CI) of these differences, were calculated 
using Confidence Interval Analysis (C.I.A., version 2.1.2 Build 
50, University of Southampton, UK).
Ethical approval
This study was approved by the Committee for Research on 
Human Subjects of the University of the Witwatersrand.
Results
Influenza and RSV seasons
The weekly isolations are represented in Fig. 1. The severe (and 
early) 1998 influenza season was essentially RSV-free and was 
sandwiched for comparison between the mild 1997 influenza 
season with a separate RSV season and the moderately severe 
1999 season with an overlapping RSV season. Influenza 
subtype A/Sydney/5/97-like H3N2 was dominant in all three 
seasons.
Mortality
The squared-coherency between influenza season and all-
cause adult medical mortality was 0.90 (Fig. 2). Modelling for 
lag periods at the end of a season did not affect the results 
(results not shown). In Table I, all-cause mortality for the entire 
hospital (adult and paediatric) and all-cause mortality for the 
adult medical department are presented. There were slightly 
more than 100 deaths per week for the hospital in the baseline 
period of each study year, of which approximately 60 occurred 
in the adult medical wards. In all three influenza seasons, total 
hospital deaths and adult medical deaths were significantly 
increased. RSV-associated mortality was not significantly 
increased in any year.
Table I shows all-cause mortality for patients ≥65 years old 
in the adult medical wards. Mortality increased by 80% in the 
severe 1998 influenza season and was significant across all 
influenza seasons. The elderly accounted for 31%, 64% and 42% 
of deaths in 1997, 1998 and 1999, respectively. All-cause deaths 
for those aged <65 years  significantly increased in the mild 

















































































Fig. 1. Seasonal distribution of influenza and RSV isolates 1997 - 1999 by 
week and month.
Fig. 2. Weekly influenza isolates and all-cause adult medical mortality.
Figure 2. Correlation between influenza season and adult all-cause mortality
Fig. 2. Weekly influenza isolates and all-cause adult medical mortality.
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1997 season and the overlapping 1999 season (Table II). RSV 
season excess deaths were not significant in either age group.
Table II shows the excess death rates/100 000 population for 
Soweto adults. For those ≥65 years of age, the excess mortality 
rate was 220.9/100 000 in the severe 1998 season, and 82.8/ 
100 000 in the mild 1997 season.
Hospitalisation
The mean weekly hospitalisation in the adult medical wards in 
the baseline period increased from 561 in 1997 to 596 in 1998 
and 611 in 1999. Only in the 1998 influenza season alone was 
there a significant increase in weekly admissions to 678 – an 
increase of 14% (95% CI 8 - 20%). This increase in admissions 
in the 1998 influenza season was 88.4/100 000 population. No 
significant RSV-related increase was found (data not shown).
Discussion
In our 3-year study, influenza seasons were significantly 
associated with excess all-cause mortality in adults (except 
in 18 - 64-year-olds in 1998), particularly in the elderly, and 
with excess all-cause medical hospitalisation in the severe 
1998 season only. RSV did not significantly affect mortality or 
hospitalisation.
The occurrence of the severe 1998 H3N2 influenza season 
sandwiched by the mild 1997 season and the intermediate 
1999 season provided a useful period for studying the impact 
of influenza seasons on hospitalisation and mortality in a 
previously unstudied community and country. After taking 
the RSV seasons into consideration, the 1999 season was 
compromised by the marked overlap of the two seasons, i.e. 
one could not place as much store on the results from 1999 
owing to the overlap of RSV and flu.
We used a rate-difference method to estimate the effects of 
influenza and RSV season on hospitalisation and mortality as 
we had only three seasons to consider.5 A potential weakness is 
that this method does not control for seasonal effects. Against 
this significant confounder was the early epidemic in 1998 and 
that RSV covered similar periods and was not found to have a 
significant impact. As in most other studies, the viral seasons 
were based on surveillance data and the infections were not 
directly confirmed.
The mortality in the elderly in 1998 of 221/100 000 is among 
the highest recorded. In the developed world, all-cause 
mortality in the elderly ranges from 116 to 136/100 000 but 
mortality is smoothed out over a number of seasons.3,6-8 In the 
USA, ≥90% of deaths occur in those aged ≥65 years. In Soweto, 
this ranged from 31% to 64% by year, largely because the 
elderly represented only 6% of adults. There was a significant 
influence on mortality in those aged 18 - 64 years in 1997 and 
1999 at a similar rate to the 6.4 - 12.5/100 000 found in those 
aged 50 - 64 years in developed countries.3,6-8,16
Although the impact of RSV on mortality did not reach 
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similar to those of high-income countries.3,5-7,12 The burden of 
RSV warrants further study across more seasons in this setting.
The increase in influenza-associated mortality across all 
seasons was not mirrored in hospitalisation figures; this may be 
partly explained by the increasing number of patients admitted 
over the years of the study, mostly owing to HIV-related 
disease, which might have caused a loss of seasonality.
There are limitations to this study, which was conducted in 
a paper-based system without back-up data sources or disease 
classifications. It was performed in a single, large hospital, the 
only public sector hospital in Soweto. Approximately 80% of 
the population does not have medical aid cover for private 
sector health services, and most of them would use public 
hospitals. We did not adjust the population denominator for 
those who might have accessed private medical care or used 
other hospitals, as there was no information on which to base 
such adjustment. Some people would have died at home. 
People from outside Soweto might have used this hospital, 
as a Soweto address was needed to ensure hospitalisation. In 
our opinion, the excess rates in this study would represent 
a minimum estimate for the effect of influenza in Soweto. 
The influenza and RSV seasons overlapped in 1999 and the 
effects of each season could not be separated. The seasons 
were discrete in 1997 and 1998; in those years, only influenza-
attributable increases reached significance, and modelling for 
lag periods at the end of a season did not affect the results. 
Inadequate data precluded a study of hospitalisation by age 
and consideration of influenza- and RSV-related conditions. 
Growing numbers of HIV-related admissions might have 
affected excess hospitalisation and possibly mortality data. 
HIV infection may exacerbate the severity of influenza17 but, 
because few patients had been tested, we did not use data on 
HIV infection.
South Africa’s guidelines for using influenza vaccine focus 
on the elderly and people with high-risk conditions.18 As far 
as we could ascertain, there was almost no usage of influenza 
vaccine in the community of Soweto during this study. 
Therefore, influenza vaccine should be provided to the elderly 
of Soweto until new strategies or vaccines become available. 
Controversy surrounds evidence for the degree of effectiveness 
of influenza vaccine in the elderly.19,20 A long-term study of a 
defined home-based (i.e. non-institutionalised) community 
designed to answer some criticisms of previous studies, 
demonstrated a 27% reduction in the risk of hospitalisation 
for pneumonia or influenza, and a 48% reduction in the 
risk of death.21 A case control study on the effectiveness of 
influenza vaccination in the elderly over one season was done 
by a South African private medical funding organisation. 
The research results were inconclusive, owing to a relatively 
mild season, limitations inherent in the study design and 
potential confounders.22 Since the influenza season in the 
southern hemisphere occurs after that in the northern season, 
the match between circulating viruses and vaccine strains is 
generally better. A vaccination programme in this vaccine-naïve 
population could answer some of the remaining questions on 
the effects of vaccination of the elderly.
Conclusion
Influenza had an important effect on mortality among adults 
in Soweto, particularly those ≥65 years old, across seasons of 
varying severity. Its effect on hospitalisation was significant 
only in the most severe season. An influenza vaccination 
programme targeting the elderly appears to be a logical 
outcome of this study.
Surveillance data were provided by Barry Schoub and Jo 
McAnerney of the National Institute of Communicable Diseases. 
Triclinium CRO (contract research organisation), Dorothy 
Hlatshwayo and Mark Rubery assisted with data collection. Sanofi-
Pasteur supported the study.
Table II.  Annual excess deaths/100 000 population in Soweto, based on the 1996 census, for influenza and RSV for the entire 
hospital, and for adult medical deaths as a whole and by age ≥65 and <65 years, 1997 - 1999 
                        Influenza             RSV
Burden     Year          Population             N excess events       Rate/105     N excess events           Rate/105
Hospital mortality    1997            894 113  140           15.7             46                5.1
     1998    193           21.6             94                10.5
     1999    127           14.2             59                6.6
Adult     1997           648 240  110           17.0             88                13.6
medical      1998    139           21.4             22                3.4
mortality     1999    156           24.1             60                9.3
Mortality      1997           39 833  33           82.8             37                92.9
≥65 years     1998    88           220.9             28                70.2
     1999    65           163.2             44               110.5
Mortality      1997          608 407  72           11.8             51                8.4
<65 years     1998    50           8.2             0                0
     1999    88           14.5             16                2.6
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